Screener

Eligibility screening

GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Sponsored by Generate BiomedicinesStudy detailsClinicalTrials.gov

2 US sites in FL, NY

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.